11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA
Conference Series LLC cordially invite the contributors across the globe to its 11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics, which is slated at Phoenix, USA during September 12-14, 2016. Sign up today and attend all three days that make up this exclusive conference successful.
- (1888PressRelease) April 06, 2016 - Recommended Vaccines Conferences | American Vaccines Congress | Immunology Conferences
Vaccines conference in Phoenix aims to promote and share knowledge on current research & production of vaccines. The conference gathers Immunology specialists, Scientists, Professors and research faculty from academia, Clinical, Veterinary, Medical, CEO's, Presidents, Policy makers, Professionals from regulatory agencies, Public health professionals, Business delegates of vaccines, Value Chain community of the vaccines with the following profession areas: Innovators, Disruptors, and Influencers, Post doc and PhD students in allied disciplines across the globe under a single roof gather in Phoenix to speak on current research on vaccination and future strategies for development and production of vaccines.
Various pharmaceutical companies are developing novel vaccines for diseases such as breast cancer, lung cancer, Alzheimer's, etc. Vaccines are becoming a key source for the pharmaceutical industry changing status of the vaccines within the pharma industry becoming new business model for vaccines. Newer and more expensive vaccines are coming into the market faster than ever before which leads to growing concentration in OECD countries but also newcomers.
Safety concerns are associated with some vaccines and the risk is estimated at 1-2 cases per million doses of vaccine. For example, MMR Measles component may cause feverish convulsions in 1:1000 children ratio. Diphtheria Neurological reactions have been reported but the risk is too small to quantify. In general, BCG vaccine severe reactions occur at injection site which is usually associated with faulty vaccination technique, however overall estimated risk is less than 1 in 200,000 vaccinations.
Vaccines Business tripled in value from $5 Billion USD in 2000 to almost $24 Billion USD in 2013, Global market expected to rise to $100 Billion USD by 2025. More than 120 new products are in development pipeline from 60 developing countries.
UNICEF had a market of $1.03 Billion USD and PAHO had $400 million USD in 2011 and total value of vaccines in UN market of $340 million USD in 2002. The global therapeutic vaccines market was valued at $294 million USD.
Contact
Johann Cruyff
americanvaccines ( @ ) conferenceseries dot net
http://vaccines.global-summit.com/america/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam